Search

Your search keyword '"H19"' showing total 1,766 results

Search Constraints

Start Over You searched for: Descriptor "H19" Remove constraint Descriptor: "H19"
1,766 results on '"H19"'

Search Results

1. LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells.

2. The Role of Long Non-Coding RNAs in Ovarian Cancer Cells.

3. Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways.

4. Association of Polymorphic Loci of Long Noncoding RNA Genes (H19, MEG3, MALAT1, LINC00305, LINC00261, LINC02227, and CDKN2B-AS1) with Chronic Obstructive Pulmonary Disease.

5. Inflammatory markers and noncoding‐RNAs responses to low and high compressions of HIIT with or without berberine supplementation in middle‐aged men with prediabetes.

6. Epigenetic modulation of long noncoding RNA H19 in oral squamous cell carcinoma-A narrative review

7. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells

8. Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression.

9. A protective role of nintedanib in peritoneal fibrosis through H19–EZH2–KLF2 axis via impeding mesothelial-to-mesenchymal transition.

10. Hypoxic adipose stem cell‐derived exosomes carrying high‐abundant USP22 facilitate cutaneous wound healing through stabilizing HIF‐1α and upregulating lncRNA H19.

11. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.

12. Analysis of VEGF, IGF1/2 and the Long Noncoding RNA (lncRNA) H19 Expression in Polish Women with Endometriosis.

13. Increased H19 /miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway.

14. Knockdown H19 Accelerated iPSCs Reprogramming through Epigenetic Modifications and Mesenchymal-to-Epithelial Transition.

15. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.

16. lncRNA Biomarkers of Glioblastoma Multiforme †.

17. N-acetyl-L-cysteine reduces testis ROS in obese fathers but fails in protecting offspring from acquisition of epigenetic traits at cyp19a1 and IGF11/H19 ICR loci

18. Inflammatory markers and noncoding‐RNAs responses to low and high compressions of HIIT with or without berberine supplementation in middle‐aged men with prediabetes

21. The Expression of TP53TG1, LINC00342, MALAT1, H19, and MEG3 Long Noncoding RNAs in Type 2 diabetes mellitus.

22. Association of long noncoding RNA H19 rs2839698 C/T with hepatitis B virus infection and hepatocellular carcinoma risk.

23. LncRNA H19 Inhibits Keratinocyte Cell Proliferation and Migration by Targeting miR-17-5p/RUNX1 Axis in Chronic Wounds.

24. Expression analysis of vitamin D receptor-associated long noncoding RNAs in patients with relapsing-remitting multiple sclerosis.

25. Association Between rs217727 and rs2839698 H19 Polymorphisms and Obesity.

26. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma

27. Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer

28. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers

29. The Role of Long Non-Coding RNAs in Ovarian Cancer Cells

31. Expression, Functional Polymorphism, and Diagnostic Values of MIAT rs2331291 and H19 rs217727 Long Non-Coding RNAs in Cerebral Ischemic Stroke Egyptian Patients.

32. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers.

33. Зміни експресії довгих некодуючих РНК H19, TUG1, GAS5, MIAT при ішемії-реперфузії міокарда.

34. Long Non-coding RNA Genes Polymorphisms H19 (rs2251375) and MALAT1 (rs3200401) Association with Rheumatoid Arthritis and Their Correlation with Disease Activity in a Cohort of Egyptian Patients: A Pilot Study.

35. Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients' Blood.

36. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.

37. C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme

38. rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population

39. Transgenerational inheritance of adrenal steroidogenesis inhibition induced by prenatal dexamethasone exposure and its intrauterine mechanism

40. Increased H19/miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway

41. Analysis of VEGF, IGF1/2 and the Long Noncoding RNA (lncRNA) H19 Expression in Polish Women with Endometriosis

43. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis

44. Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases

45. Transgenerational inheritance of adrenal steroidogenesis inhibition induced by prenatal dexamethasone exposure and its intrauterine mechanism.

46. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.

47. H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients.

48. M1 macrophage‐derived exosomes promote autoimmune liver injury by transferring long noncoding RNA H19 to hepatocytes.

49. 长链非编码 RNA H19 通过 miR-4735-3p/HIF-1α 信号轴介导姜黄素抑制甲状腺癌上皮 ̄间质转化.

50. Altered Expression of Long Non-Coding RNAs NEAT1, H19, and MALAT1 in Peripheral Blood ‎Cells of Patients with Allergic Rhinitis after Treatment with Pharmaceutical Combinations of ‎ Budesonide and Fexofenadine versus Fluticasone Propionate and Fexofenadine

Catalog

Books, media, physical & digital resources